Creative Consultants



About us

Services

Registration Dossiers
SPC
Preclinical Expert Report
Clinical Expert Report
Package Inserts
Patient Leaflets
Medical Writing

Contact us

REPRODUCTION TOXICITY

Fertility and Reproduction Studies

Animal species used

No. of animals

Routes of admn.

Dosage used

Duration

Male rats

 

Female rats

Not available

 

Not available

Oral



Oral

20, 100, or 175 mg/kg


20, 100, or 225 mg/kg

11 weeks before mating to 115 days after mating

2 weeks prior to mating to gestation Day 7

Results :

Males :  Dose-related body weight gain suppressions of 17 and 25%, and food consumption suppressions of 7 and 16%, occurred during the 11-week premating treatment period at 100 and 175 mg/kg, respectively, compared with vehicle controls. There were no treatment-related effects on testes, epididymides or accessory organs weights, testicular or epididymal sperm counts, sperm motility, or sperm morphology during Week 15 of treatment. There were no effects on copulation or fertility indices, number of days to mating, or female reproductive parameters (number of implants, live fetuses, or pre- and postimplantation loss).(23)

Females : The mean number of estrous cycles, copulation and fertility indices, number of days to mating, and number of viable litters were comparable between groups. In addition, term sacrifice parameters (number of corpora lutea, implants, live fetuses, pre- and postimplantation loss) were not significantly different between groups.(23)

Teratogenic Effects

Animal species used

No. of animals

Routes of admn.

Dosage used

Duration

Rats

20

Oral

0, 10, 100, or 300 mg/kg

days 6-15 of gestation

Results :

At 300 mg/kg in rats, 1 treatment-related death occurred on day 12 of gestation and maternal body weight gain and food consumption were decreased during treatment (43% and 23%, respectively). In addition, 1 animal at 300 mg/kg had total litter resorption. Increased postimplantation loss (not statistically significant) and slightly decreased fetal body weight (statistically significant only in males) were also observed at 300 mg/kg. There were no significant differences between treated and control groups in the incidence of fetal malformations or variations. No maternal or developmental toxicity was observed in rats at 10 or 100 mg/kg.(24)

Animal species used

No. of animals

Routes of admn.

Dosage used

Duration

Rabbits

29

Oral

0, 10, 50, or 100 mg/kg

days 6-18 of gestation.

Results :

In rabbits, marked maternal toxicity (7 deaths, body weight loss during and after treatment, and decreased food consumption) and abortion occurred at 100 mg/kg. At 50 mg/kg, maternal toxicity (2 deaths and 72% body weight gain suppression) and abortion also occurred. There were no treatment-related effects on live litter size or sex ratio. At 50 and 100 mg/kg, nonstatistically significant increases in postimplantation loss and decreases in gravid uterine weight were observed, and at 100 mg/kg, decreases in fetal body weight were observed relative to controls.(24)

Animal species used

No. of animals

Routes of admn.

Dosage used

Duration

Female Sprague-Dawley rats

Not available

Oral

0, 20, 100, or 225 mg/kg daily by

gestation day 7 through lactation day 20

Results :

Offspring survival at birth and during the neonatal period at 225 mg/kg was reduced relative to control by up to 45%, and 28% of litters had no viable offspring by 10 days postpartum. Additional effects on offspring included reduced body weight during the neonatal and maturation periods (100, 225 mg/kg), delayed appearance of pinnae detachment and incisor eruption (225 mg/kg), impaired rotorod performance (females only; 100, 225 mg/kg), reduced acoustic startle responding (males only; 20, 100, 225 mg/kg), and transient effects on shuttle avoidance (females only; 225 mg/kg). No treatment-related effects were observed on offspring reproduction.(25)